Lipophilicity and Transporter Influence on Blood-Retinal Barrier Permeability: A Comparison with Blood-Brain Barrier Permeability
暂无分享,去创建一个
[1] S. Akanuma,et al. Blood-to-retina transport of biotin via Na+-dependent multivitamin transporter (SMVT) at the inner blood-retinal barrier. , 2010, Experimental eye research.
[2] M. Tomi,et al. Involvement of system A in the retina-to-blood transport of l-proline across the inner blood-retinal barrier. , 2010, Experimental eye research.
[3] Uday B Kompella,et al. RETRACTION: Influence of Lipophilicity on Drug Partitioning into Sclera, Choroid-Retinal Pigment Epithelium, Retina, Trabecular Meshwork, and Optic Nerve , 2010, Journal of Pharmacology and Experimental Therapeutics.
[4] S. Akanuma,et al. Characteristics of glycine transport across the inner blood–retinal barrier , 2009, Neurochemistry International.
[5] M. Tomi,et al. Cationic amino acid transporter 1‐mediated l‐arginine transport at the inner blood–retinal barrier , 2009, Journal of neurochemistry.
[6] A. Negi,et al. Expression of ATP-binding cassette transporters at the inner blood–retinal barrier in a neonatal mouse model of oxygen-induced retinopathy , 2009, Brain Research.
[7] M. Tachikawa,et al. Inner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery , 2009, Pharmaceutical Research.
[8] T. Terasaki,et al. Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine , 2009, Journal of Pharmacology and Experimental Therapeutics.
[9] T. Dinan,et al. Verapamil in treatment resistant depression: a role for the P‐glycoprotein transporter? , 2009, Human psychopharmacology.
[10] W. Löscher,et al. Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (R)-11C-Verapamil and PET , 2008, Journal of Nuclear Medicine.
[11] R. Deane,et al. Thyroxine (T4) transfer from CSF to choroid plexus and ventricular brain regions in rabbit: Contributory role of P-glycoprotein and organic anion transporting polypeptides , 2007, Brain Research.
[12] 長瀬 克彦. Functional and molecular characterization of adenosine transport at the rat inner blood-retinal barrier , 2007 .
[13] Masahiko Watanabe,et al. ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells , 2006, Pharmaceutical Research.
[14] P. Sinko,et al. THE BLOOD-BRAIN BARRIER SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER: A MOLECULAR FUNCTIONAL IN VITRO-IN SITU CORRELATION , 2005, Drug Metabolism and Disposition.
[15] T. Terasaki,et al. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier. , 2005, Investigative ophthalmology & visual science.
[16] F. Russel,et al. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. , 2004, Journal of the American Society of Nephrology : JASN.
[17] P. Wielinga,et al. Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy , 2004, Molecular and Cellular Biology.
[18] Masahiko Watanabe,et al. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte‐derived soluble factor(s) , 2004, Journal of neurochemistry.
[19] N. Abbott,et al. Brain to blood efflux transport of adenosine: blood–brain barrier studies in the rat , 2004, Journal of neurochemistry.
[20] J. LaManna,et al. Comparison of Glucose Influx and Blood Flow in Retina and Brain of Diabetic Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] J. Cunha-Vaz. The blood-retinal barriers system. Basic concepts and clinical evaluation. , 2004, Experimental eye research.
[22] S. Ishikawa,et al. Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier , 2003, Journal of Biological Chemistry.
[23] H. Takanaga,et al. Rat Organic Anion Transporter 3 (rOAT3) is Responsible for Brain-to-Blood Efflux of Homovanillic Acid at the Abluminal Membrane of Brain Capillary Endothelial Cells , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] D. Forrest,et al. Neurodevelopmental control by thyroid hormone receptors , 2002, Current Opinion in Neurobiology.
[25] D. Hu,et al. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.
[26] T. Tsuruo,et al. The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier , 2000, Brain Research.
[27] W. Pardridge,et al. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Moshfeghi,et al. Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. , 1997, Experimental eye research.
[29] Y. Sugiyama,et al. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method. , 1997, The Journal of pharmacology and experimental therapeutics.
[30] I. Bodis-Wollner. Visual Electrophysiology in Parkinson's Disease: PERG, VEP and Visual P300 , 1997, Clinical EEG.
[31] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[32] U. Tuor,et al. Blood‐eye barriers in the rat: Correlation of ultrastructure with function , 1994, The Journal of comparative neurology.
[33] Q. Smith,et al. Identification of the Cationic Amino Acid Transporter (System y+) of the Rat Blood‐Brain Barrier , 1993, Journal of neurochemistry.
[34] O. Ezaki,et al. Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat. , 1992, Investigative ophthalmology & visual science.
[35] W. Pardridge,et al. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. , 1990, The Journal of biological chemistry.
[36] W. Pardridge,et al. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] S. Vanchilingam,et al. Effect of L‐dopa on visual evoked potential in patients with Parkinson's disease , 1986, Neurology.
[38] A. Betz,et al. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. , 1986, Investigative ophthalmology & visual science.
[39] W. Pardridge,et al. Blood—Brain Barrier Transport of Butanol and Water Relative to N-Isopropyl-p-Iodoamphetamine as the Internal Reference , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] A. Alm,et al. The uptake index method applied to studies on the blood-retinal barrier. I. A methodological study. , 1981, Acta physiologica Scandinavica.
[41] Victor A. Levin,et al. RELATIONSHIP OF OCTANOL/WATER PARTITION COEFFICIENT AND MOLECULAR WEIGHT TO RAT BRAIN CAPILLARY PERMEABILITY , 1980 .
[42] B. J. Davidson,et al. Effects of human serum on transport of testosterone and estradiol into rat brain. , 1980, The American journal of physiology.
[43] W. Pardridge,et al. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. , 1979, The Journal of clinical investigation.
[44] C. Crone,et al. THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.
[45] M. Tomi,et al. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier. , 2010, Investigative ophthalmology & visual science.
[46] M. Tomi,et al. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. , 2005, Biological & pharmaceutical bulletin.
[47] A. Alm,et al. Carrier-mediated transport of amino acids through the blood-retinal and the blood-brain barriers , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[48] T. Tsuruo,et al. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. , 1992, Life sciences.
[49] E. Cornford. The blood-brain barrier, a dynamic regulatory interface , 1985 .
[50] N. V. van Haeringen,et al. Selective properties of the vitreous barrier. , 1968, Experimental eye research.
[51] Torsten Husén,et al. A methodological study , 1959 .